Emerging treatments in multiple sclerosis.

Abstract

Currently used and developing therapies for multiple sclerosis (MS) are dealing with the treatment of acute exacerbations, the prevention of relapses and of the progression of neurological handicap, the treatment of symptoms, and the repair of demyelinated lesions. New insights into the treatment of acute relapses as well as recent immunomodulatory and immunosuppressive agents tested in MS are exposed in this brief review. Interferon-beta (1a and 1b), copolymer 1 and new immunosuppressive therapies are particularly discussed with emphasis on their potential to alter the course of MS.

Statistics

0100200300'05'06'07'08'09'10'11'12'13'14'15'16'17
Citations per Year

93 Citations

Semantic Scholar estimates that this publication has 93 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Schluep1997EmergingTI, title={Emerging treatments in multiple sclerosis.}, author={Myriam Schluep and Julien Bogousslavsky}, journal={European neurology}, year={1997}, volume={38 3}, pages={216-21} }